Loading market dashboard
Prestige Consumer Healthcare Inc.
PBHHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE: PBH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE: PBH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Prestige Consumer Healthcare Inc. (NYSE: PBH) ("Prestige Consumer Healthcare Inc.") concerning potential violations of the federal securities laws. During the Q3 FY 2026 earnings call, CEO Ron Lombardi stated that Prestige Consumer Healthcare anticipated a 57% adjusted gross margin in Q4.
LOS ANGELES, May 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or "the Company") (NYSE: PBH) for violations of the securities laws.
LOS ANGELES, May 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or “the Company”) (NYSE: PBH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On M.
Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (âPrestige Consumerâ or the âCompanyâ) (NYSE: [url=
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PRESTIGE CONSUMER HEALTHCARE (PBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 13, 2026, Prestige Consumer annou.
Prestige Consumer Healthcare shares fell sharply after Q4 earnings missed consensus estimates -- adjusted EPS came in at $1.23 versus the $1.39 expected, driven by unresolved supply-chain constraints management had assured investors were improving. NEW YORK, May 22, 2026 /PRNewswire/ -- Prestige Consumer Healthcare, Inc. (NYSE: PBH) investors suffered significant losses when the stock dropped after the Company reported Q4 fiscal 2026 earnings well below expectations, with adjusted EPS of $1.23 versus the $1.39 consensus estimate and revenue of $281.6 million falling short of forecasts.
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK--(BUSINESS WIRE)--Shareholders who lost money on Prestige Consumer Healthcare (NYSE: PBH) stock following the Company's Q4 FY 2026 earnings miss are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. During the Q3 FY 2026 earnings call, CEO Ron Lombardi highlighted that management had “narrowed our sales outlook,” revising revenue expectations to the floo.
ATLANTA, May 19, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Prestige Consumer Healthcare Inc. (“Prestige Consumer” or the “Company”) (NYSE: PBH) complied with federal securities laws. On May 13, 2026, Prestige Consumer reported fourth quarter and full year 2026 financial results revealing that revenues decreased by 5% compared to the fourth fiscal quarter 2025 and by 4.5% versus the prior fiscal year excluding the impact of foreign currency.
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company's possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR.
Law Offices of Howard G. Smith announces an investigation on behalf of Prestige Consumer Healthcare (âPrestige Consumerâ or the âCompanyâ) (NYSE: [url="
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PRESTIGE CONSUMER HEALTHCARE (PBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss y.
New York, New York--(Newsfile Corp. - May 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Prestige Consumer Healthcare Inc. (NYSE: PBH) ("Prestige Consumer Healthcare Inc.") concerning potential violations of the federal securities laws. During the Q3 FY 2026 earnings call, CEO Ron Lombardi stated that Prestige Consumer Healthcare anticipated a 57% adjusted gross margin in Q4.
Prestige ended its Fiscal Year 2026 with a big earnings miss. It appears the company will have a fairly slow start to FY'27 as well. Acquisitions should add significantly to the top line, but they will add more debt to an already leveraged balance sheet.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 13, 2026, Prestige Consumer announ.
New York, New York--(Newsfile Corp. - May 15, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Prestige Consumer Healthcare Inc. ("Prestige Consumer Healthcare Inc.") (NYSE: PBH) concerning potential violations of the federal securities laws. During the Q3 FY 2026 earnings call, CEO Ron Lombardi stated that Prestige Consumer Healthcare anticipated a 57% adjusted gross margin in Q4.
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.23 per share, missing the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.32 per share a year ago.
The headline numbers for Prestige Consumer Healthcare (PBH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Premium Brands Holdings Corporation (PBH:CA) Q1 2026 Earnings Call Prepared Remarks Transcript
TARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2026.
Premium Brands Holdings Corporation (PBH:CA) Q1 2026 Earnings Call Transcript
Beyond analysts' top-and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
TARRYTOWN, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 fourth quarter and year-end earnings release on Wednesday, May 13, 2026 after the market close.
On April 29, 2026, Prestige Consumer Healthcare Inc (PBH) shares fell 4.7% to a current price of $56.02. The stock has experienced a challenging year, now tradi
Premium Brands has dropped into my $80–$90 buy range, presenting a compelling entry after a sharp pullback. PBH's M&A pipeline has slowed, but the Stampede acquisition adds significant U.S. capacity and growth potential, despite some near-term margin dilution. Management is shifting toward equity-funded acquisitions to protect leverage, likely resulting in higher share count but maintaining balance sheet flexibility.
Boring, cash-generating businesses like regional grocers often shine when uncertainty rises in the market. These three tickers are the kinds of steady names you build into slowly as volatility creates opportunities.
Jin Medical International (NASDAQ: ZJYL - Get Free Report) and Prestige Consumer Healthcare (NYSE: PBH - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings. Volatility and Risk Jin Medical International
Prestige Consumer Healthcare Inc. (NYSE: PBH - Get Free Report) has been assigned an average recommendation of "Hold" from the seven research firms that are covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year target price
Premium Brands (TSE: PBH) executives said the company finished fiscal 2025 with strong sales growth and improving fourth-quarter profitability despite what management described as significant commodity inflation headwinds, particularly record-high beef costs for most of the year and higher chicken costs in the first half. On the company's year-end conference call, CEO George Paleologou and CFO
Premium Brands Holdings Corporation (PBH:CA) Q4 2025 Earnings Call Transcript
Prestige signed a deal to buy a portfolio of brands that includes the Breathe Right nasal strip from privately held Foundation Consumer Healthcare.
TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million.
Premium Brands Holdings Corporation (PBH:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
These companies acquire established consumer brands with loyal customers, then improve margins and cash flow through efficiency efforts. Pet care, lawn and garden, and OTC healthcare products generate consistent demand, making these easy long-term wealth builders.
